期刊文献+

东莞地区儿童肺炎链球菌携带率及耐药性检测 被引量:1

Examination of antibiotic resistance of streptococcus pneumoniae isolated from children in Dongguan City
下载PDF
导出
摘要 目的分析东莞地区学龄前健康儿童鼻咽部携带肺炎链球菌情况及对常用抗生素的耐药特点,为预防儿童肺炎链球菌感染及合理使用抗生素提供参考。方法采用专用巧克力平板和血平板培养基,对采集的350例3~5岁儿童鼻咽部分泌物作培养鉴定,对鉴定明确的肺炎链球菌根据美国临床实验室标准化委员会(NCCLS)标准进行常用抗生素检测。结果东莞地区儿童肺炎链球菌携带率约为34.5%;携带株对左旋氧氟沙星、氯霉素、复方新诺明、苯唑西林、四环素、红霉素和青霉素的耐药率分别是2%、24%、42%、64%、74%、78%和24%,仅对万古霉素敏感。结论东莞地区健康学龄前儿童鼻咽部肺炎链球菌携带率高于国内许多地区,对常用抗生素耐药性严重,并存在多重耐药现象。 Objective To analyze streptococcus pneumoniae(SP) isolated from healthy children in Dongguan City and their antibiotic resistance. Methods 350 samples of rhinopharyngeal secretion from children aged 3 to 5 years old were cultured with special chocolate and blood medium. SP and Hi isolated were tested for antibiotic susceptibility according to NCCLS. Results The detection rate of SP was 34.5%. The resistance rates of SP to LEV, C, SXT, OX, TE, E and PG were 2%, 24%, 42%, 64 %,74 %,78% and 24 % respectively. Conclusion The detection rate of Sp in children in Dongguan City is higher than in other regions. And the situation of resistance to antibiotic and multi-resistant is serious.
出处 《国外医学(临床生物化学与检验学分册)》 2005年第12期865-866,共2页 Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
基金 广东省东莞市医学科研资助项目(20040718)
关键词 链球菌 肺炎 微生物敏感性试验 药物耐受性 儿童 Streptococcus pneumoniae Microbioc sensitivity tests Drug tolerance Child
  • 相关文献

参考文献9

二级参考文献54

  • 1俞桑洁,傅曙光,佟月娟,李艳,杨永弘.130株肺炎链球菌对青霉素类耐药的研究[J].中华儿科杂志,1996,34(6):369-371. 被引量:15
  • 2Di Guilmi AM, Dessen A. New approaches towards the identification of antibiotic and vaccine targets in Streptococcus pneumoniae. EMBO Rep, 2002, 3(8):728- 734.
  • 3Cochran JB, Panzarino VM, Maes LY, et al. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol, 2004, 19(3):317- 321.
  • 4Loeffler JM, Garbino J, Lew D, et al. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis, 2003, 35( 11 - 12): 843 - 850.
  • 5McCracken GH. Etiology and treatment of pneumonia.Pediatr Infect Dis J, 2000, 19(4): 373- 377.
  • 6Hortal M, Lovgren M, de la Hoz F, et al. Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries: 1993- 1999 surveillance. Microb Drug Resist, 2001, 7(4) :391 - 401.
  • 7Evans ME. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin,levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin. Eur J Clin Microbiol Infect Dis, 2001,20(12) :883- 885.
  • 8Jones RN.Microbiology of newer fluoroquinolones:focus on respiratory pathogens. Diagn Microbiol Infect Dis, 2002, 44(3) :213 - 220.
  • 9Chapman TM, Perry CM. Cefepime:a review of its use in the management of hospitalized patients with pneumonia. Am J Respir Med, 2003, 2(1): 75 - 107.
  • 10Hsu KK, Pelton SI. Heptavalent pneumococcal conjugate vaccine: current and future impact. Expert Rev Vaccines, 2003, 2(5): 619 - 631.

共引文献137

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部